TouchIMMUNOLOGY were delighted to talk with Professor Luis Ostrosky (Infectious diseases, UTHealth, Houston, TX, USA) around his presentation titled ‘COVID-19: Update on Therapeutics‘, which was presented at the ACR Convergence, 3-9 November 2021.
This information is brought to you by Touch Medical Media and is not sponsored by, nor a part of, the American College of Rheumatology.
Questions
- What are the challenges presented by interpreting clinical study data of potential therapeutic options for COVID-19? (0:26)
- What are the latest recommendations on neutralising monoclonal antibodies and IL-6 blockers? (1:15)
- What novel strategies seem promising for the treatment of patients with COVID-19? (3:10)
Disclosures: Dr. Ostrosky has received research funding and/or personal fees from Abbott, Gilead, Octpharma, Pfizer, and GigaGen.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
Filmed in coverage of the virtual ACR Convergence 2021.
